Showing results (191-200 of 230) with videos related to
Sort By:
Pageof 23
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|January 20, 2009
Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trialsJordana Kron, Juan M Aranda, William M Miles, et al.Innate Immunity|May 29, 2012
The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout miceM Rachel Richards, Audrey S Black, David J Bonnet, et al.The Journal of Biological Chemistry|October 24, 2008
Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanismYankun Li, Yuan Zhang, Bernhard Dorweiler, et al.Evolution, Medicine, and Public Health|September 8, 2025
Higher blood lipid levels after the transition to menopause in two forager-horticulturalist populationsM J Getz, J E Aronoff, C L Jenkins, et al.Scientific Reports|January 30, 2020
Stacking Fault Energy Analyses of Additively Manufactured Stainless Steel 316L and CrCoNi Medium Entropy Alloy Using In Situ Neutron DiffractionW Woo, J S Jeong, D-K Kim, et al.The Journal of Pharmacy and Pharmacology|March 4, 2000
Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and ratsS K Sohn, M S Chang, W S Choi, et al.Journal of Korean Medical Science|October 20, 2001
Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseasesS Y Kim, C W Woo, Y M Lee, et al.Transplantation|April 24, 2008
Incidence, predictors, and outcomes of cardiac pacing after cardiac transplantation: an 11-year retrospective analysisGregory W Woo, Richard S Schofield, Daniel F Pauly, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapyPaul A Foster, Simon P Newman, Surinder K Chander, et al.Journal of the American College of Cardiology|September 19, 1998
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatinA S Brown, R G Bakker-Arkema, L Yellen, et al.Pageof 23